Protalix BioTherapeutics
PLX
#8714
Rank
HK$0.80 B
Marketcap
HK$10.97
Share price
13.71%
Change (1 day)
2.56%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -HK$0.11 Billion

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are HK$38.05 Million. In 2023 the company made an earning of HK$91.45 Million, an increase over its 2022 earnings that were of -HK$92.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$0.11 Billion-212.48%
2023 HK$91.45 M-199.05%
2022 -HK$92.34 Million-40.38%
2021 -HK$0.16 Billion-732.31%
2020 HK$24.49 M-130.53%
2019 -HK$80.23 Million189.85%
2018 -HK$27.68 Million-95.29%
2017 -HK$0.59 Billion308.12%
2016 -HK$0.15 Billion-32.37%
2015 -HK$0.22 Billion10.11%
2014 -HK$0.2 Billion-7.59%
2013 -HK$0.21 Billion
2011 -HK$0.25 Billion-19.39%
2010 -HK$0.31 Billion20.87%
2009 -HK$0.25 Billion32.26%
2008 -HK$0.19 Billion-5.46%
2007 -HK$0.2 Billion
2004 -HK$1.29 Million12.35%
2003 -HK$1.15 Million-11.1%
2002 -HK$1.3 Million-57.03%
2001 -HK$3.01 Million1.03%
2000 -HK$2.98 Million-53.22%
1999 -HK$6.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.78 Billion 658.72%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$5.10 B-5,090.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$9.44 Billion 9,110.43%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$6.43 B-6,384.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel